The 411 on Obesity

Join Donna Ryan, MD, Professor Emerita at the Pennington Biomedical Research Center in Baton Rouge, Louisiana; Deborah Horn, DO, Associate Professor at the University of Texas Center McGovern Medical School and Medical Director of the Center for Obesity Medicine and Metabolic Performance in Houston, Texas; and Matthew Budoff, MD, Professor of Medicine In-Residence at the David Geffen School of Medicine and Endowed Chair of Preventive Cardiology at the Lundquist Institute for Biomedical Innovation at Harbor- UCLA Medical Center in Los Angeles, California, for a conversation about the evolution of anti-obesity medicine and associated clinical practice guidelines. The panel will also discuss clinical data from a trial that evaluated a glucagon-like peptide-1 receptor agonist (GLP-1 RA) for chronic weight management in adult patients with obesity or overweight with a weight-related comorbidity. Data on the effects of the GLP-1 RA on cardiometabolic risk factors, as observed in this trial, will also be presented. Lastly, the panel will review data from a cardiovascular outcomes trial which assessed the effect of the GLP-1 RA on reducing the risk of major adverse cardiovascular events (MACE) in patients with obesity or overweight and established cardiovascular disease.Please see Prescribing Information, including boxed warning.This program is intended for clinicians. The information presented is aligned with the views and opinions of the speakers and is sponsored by Novo Nordisk. This podcast is not to be used as medical advice and is intended for educational purposes only.The moderator and expert discussants were compensated by Novo Nordisk for their participation in this podcast.Faculty Presenters:Donna Ryan, MDProfessor EmeritaPennington Biomedical Research CenterBaton Rouge, LADeborah Bade Horn, DO MPH MFOMA Medical DirectorUniversity of Texas, Center for Obesity Medicine and Metabolic Performance (COMMP)Associate ProfessorUniversity of Texas McGovern Medical School, Department of SurgeryProgram DirectorUT Allison Family Foundation Fellowship in Clinical Obesity Medicine and Metabolic PerformanceDiplomateAmerican Board of Obesity Medicine Houston, TXMatthew Jay Budoff, MDProfessor of MedicineUniversity of California Los Angeles Endowed Chair of Preventative Cardiology Lundquist InstituteTorrance, CA

Join a panel of experts including Donna Ryan, MD, Professor Emerita at the Pennington Biomedical Research Center in Baton Rouge, Louisiana; Anthony Auriemma, MD, Medical Director at Ascension Illinois Medical Group Weight Loss Solutions in Schaumburg, Illinois; and Dana Trippi, DO, Founder and Chief Medical Officer at Premier Physicians Weight Loss and Wellness in Las Vegas, Nevada, for a discussion on anti-obesity medicine and the need for clinicians to adopt a comprehensive, individualized approach to patient care. The panel will also review data from a cardiovascular outcomes trial of a glucagon- like peptide-1 receptor agonist (GLP-1 RA) in adults with obesity or overweight and established cardiovascular disease.Additionally, results from along-term weight management trial will be reviewed, including data on sustained body weight reduction at 2 years, as well as effects on cardiometabolic risk factors.Please see Prescribing Information, including boxed warning.This program is intended for clinicians. The information presented is aligned with the views and opinions of the speakers and is sponsored by Novo Nordisk. This podcast is not to be used as medical advice and is intended for educational purposes only.The moderator and expert discussants were compensated by Novo Nordisk for their participation in this podcast.Faculty Presenters:Donna Ryan, MDProfessor EmeritaPennington Biomedical Research CenterBaton Rouge, LAAnthony Auriemma, MD, JD, FOMAMarket Medical Director and Vice President of Clinical PartnershipsknownwellSchaumburg, ILDana Trippi, D.O., ABEM, DABOMFounder/Chief Medical OfficerPremier Physicians Weight Loss &WellnessLas Vegas, NV

Join panelists Donna Ryan, MD, Professor Emerita at the Pennington Biomedical Research Center in Baton Rouge, Louisiana, Ethan Lazarus, MD, Director of Clinical Nutrition Center in Denver, Colorado, and Lawrence Herman, DMSc PA-C, Adjunct Professor at the University of Lynchburg and President of Palantir Healthcare, LLC, in Greenville, South Carolina, as they address frequently asked questions about the use of glucagon-like peptide-1 receptor agonist (GLP-1 RA) in appropriate adults with obesity or overweight and at least one weight-related comorbidity. The discussion includes commonly asked questions about trial design from relevant chronic weight- management and cardiovascular outcomes trials, efficacy and safety data, and practical guidance on dosing and administration.Please see Prescribing Information, including boxed warning.This program is intended for clinicians. The information presented is aligned with the views and opinions of the speakers and is sponsored by Novo Nordisk. This podcast is not to be used as medical advice and is intended for educational purposes only.The moderator and expert discussants were compensated by Novo Nordisk for their participation in this podcast.Faculty Presenters:Donna Ryan, MDProfessor EmeritaPennington Biomedical Research CenterBaton Rouge, LAEthan Lazarus, MD, MFOMAClinical Nutrition CenterAnschutz Medical CenterDenver, COLawrence Herman, DMSc, MPA, PA-CPalantir Healthcare, LLCBoiling Springs, South CarolinaDoctor of Medical Science Program, University of LynchburgLynchburg, Virginia

Join experts in obesity Dr Donna Ryan (Professor Emerita at Pennington Biomedical Research Center, in Baton Rouge, Louisiana), Dr Jeremy McConnell (Chief Executive Officer and Founder of Florida Sleep Specialists and Discover Health Obesity Medicine Clinic, both in Bradenton, Florida), and Dr Angela Fitch (President of the Obesity Medicine Association and Co-Founder and Chief Medical Officer of knownwell, in Needham, Massachusetts) as they share their insights on the challenges of obesity and its association with certain weight-related comorbidities. The panel will also discuss the efficacy and safety of a pharmacotherapy for chronic weight management in adult patients with obesity or overweight with a weight-related comorbidity, highlighting the role of pharmacotherapy in long-term weight loss at 2 years in addition to lifestyle intervention.Please see Prescribing Information, including boxed warning.This program is intended for clinicians. The information presented is aligned with the views and opinions of the speakers and is sponsored by Novo Nordisk. This podcast is not to be used as medical advice and is intended for educational purposes only.The moderator and expert discussants were compensated for their participation in this podcast.Faculty Presenters:Donna Ryan, MDProfessor EmeritaPennington Biomedical Research CenterBaton Rouge, LAJeremy McConnell, MD, FOMA, Dipl. ABOMObesity and Sleep Medicine PhysicianFlorida Sleep Specialists & Discover HealthBradenton, FLAngela Fitch, MD, FACP, FOMAPresident Obesity Medicine AssociationChief Medical Officer and Co-Founder knownwellBoston, MA

Join experts in obesity: Dr Donna Ryan (Professor Emeritus Pennington Biomedical Research Center at Baton Rouge, LA), Dr Domenica Rubino (Endocrinologist, and Director at the Washington Center for Weight Management & Research, Arlington, Virginia), and Dr Deborah Horn (Associate Professor at the University of Texas McGovern Medical School and Medical Director at the Center for Obesity Medicine and Metabolic Performance) to discuss the efficacy and safety of a pharmacotherapy for chronic weight management in adults with obesity or overweight and with a weight-related comorbidity, the panel will also discuss results from 2 clinical trials, including a long-term studyPlease see Prescribing Information, including boxed warning.This program is intended for clinicians. The information presented is aligned with the views and opinions of the speakers and is sponsored by Novo Nordisk. This podcast is not to be used as medical advice and is intended for educational purposes only.The moderator and expert discussants were compensated for their participation in this podcast.Faculty Presenters:Donna Ryan, MDProfessor EmeritaPennington Biomedical Research CenterBaton Rouge, LouisianaDomenica Rubino, MDDirector  Washington Center for Weight Management and ResearchArlington, VA Deborah Horn, DO, MPH, MFOMAAssociate Professor, Obesity Medicine Clinician ScientistMedical Director, University of Texas, Center for Obesity Medicine and Metabolic Performance (COMMP)Associate Professor, University of Texas McGovern Medical School, Department of SurgeryProgram Director, UT Allison Family Foundation Fellowship in Clinical Obesity Medicine and Metabolic Performance Diplomate, American Board of Obesity MedicineHouston, TX